DTC television prescription medication adds have hit an all-time high at 4.
5 billion dollars last year.
But a throw down is sure to come between the new house and senate, and drug companies.
According to the New York Times, "The consumer ads will be on the griddle early in this session at hearings on the user fees that manufacturers pay to speed the reviewing of new drugs by the Food and Drug Administration.
The user fee law will die in the fall unless Congress acts to renew it.
The pharmaceutical industry, which often gets what it asks for from Congress and the executive branch, seeks to renew the law and add a new set of user fees that would be pay salaries for additional FDA employees to evaluate all consumer drug ads, before they are shown on television.
" As of late, the FDA has recently had a hard time keeping pace with big pharma's advertisements.
Many would like to see a mandatory pause in advertisement until 2 years after the product is released in order to allow doctors sufficient time to evaluate the product.
This would have proven to be useful in the case of Vioxx, Merck's heavily advertised painkiller that had to be removed from the market after it was proven to increase the risk of heart attack and strokes.
According to a survey conducted by PricewaterhouseCoopers, "Only 1 in 10 consumers said the direct-to-consumer, or D.
T.
C.
, ads could provide useful information to a large audience.
" So far, an agreement has not been reached on a suitable time delay for advertising after a products release.
Visit this Consumer Advocacy website for more information on ordering from an online Mexican pharmacy [http://www.
premiermexicanpharmacies.
com%20].
5 billion dollars last year.
But a throw down is sure to come between the new house and senate, and drug companies.
According to the New York Times, "The consumer ads will be on the griddle early in this session at hearings on the user fees that manufacturers pay to speed the reviewing of new drugs by the Food and Drug Administration.
The user fee law will die in the fall unless Congress acts to renew it.
The pharmaceutical industry, which often gets what it asks for from Congress and the executive branch, seeks to renew the law and add a new set of user fees that would be pay salaries for additional FDA employees to evaluate all consumer drug ads, before they are shown on television.
" As of late, the FDA has recently had a hard time keeping pace with big pharma's advertisements.
Many would like to see a mandatory pause in advertisement until 2 years after the product is released in order to allow doctors sufficient time to evaluate the product.
This would have proven to be useful in the case of Vioxx, Merck's heavily advertised painkiller that had to be removed from the market after it was proven to increase the risk of heart attack and strokes.
According to a survey conducted by PricewaterhouseCoopers, "Only 1 in 10 consumers said the direct-to-consumer, or D.
T.
C.
, ads could provide useful information to a large audience.
" So far, an agreement has not been reached on a suitable time delay for advertising after a products release.
Visit this Consumer Advocacy website for more information on ordering from an online Mexican pharmacy [http://www.
premiermexicanpharmacies.
com%20].